Role of baseline soluble tumor necrosis factor receptor 2 as a biomarker in primary podocytopathy: Implications for renal impairment and disease progression

Role of baseline soluble tumor necrosis factor receptor 2 as a biomarker in primary podocytopathy: Implications for renal impairment and disease progression

Abstract Background Podocytopathies, including minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and collapsing glomerulopathy (CG), are kidney diseases that damage glomerular podocytes, leading to heavy proteinuria and nephrotic syndrome (NS). Inflammation plays a critical ro...

Full description

Bibliographic Details
Main Authors: Srinivas Nagaram, Priscilla Charles, Yadav Nisha, Norton Stephen, Nandeesha Hanumanthappa, Sreejith Parameswaran, Palanivel Chinnakali, Rajesh Nachiappa Ganesh
Format: Article
Language:English
Published: BMC 2024-10-01
Series:BMC Nephrology
Subjects:
Biomarker
Tumor necrosis factor alpha
Podocytopathies
Estimated glomerular filtration rate
Chronic kidney disease
Online Access:https://doi.org/10.1186/s12882-024-03772-y

Internet

https://doi.org/10.1186/s12882-024-03772-y

Similar Items